Franklin & Seidelmann Subspecialty Radiology has expanded its subspecialty teleradiology business model to offer final and preliminary nighttime interpretations via its acquisition of Apex Radiology of Coral Gables, FL, the company announced Oct. 23.
Franklin & Seidelmann Subspecialty Radiology has expanded its subspecialty teleradiology business model to offer final and preliminary nighttime interpretations via its acquisition of Apex Radiology of Coral Gables, FL, the company announced Oct. 23.
With the acquisition, F&S expects to have an annual case volume of more than 800,000 final reports, becoming the industry's largest teleradiology provider of final reports, as well as the largest subspecialty teleradiology provider.
F&S provides clients around the country with subspecialty radiology expertise in the areas of musculoskeletal, neuroradiology, body, cardiac, oncological, pediatric, and breast MR imaging. The Apex acquisition adds 25 radiologists to bring its total radiologist count to more than 100, the company said. F&S will now serve 250 clients.
"The decision to expand our scope of services was a natural evolution of our business and driven by our clients themselves," said F&S chairman and cofounder Dr. Frank Seidelmann. "It was a logical move to expand into nighttime coverage so that a radiology group or a hospital could experience the convenience of a full-service teleradiology provider and still receive a high level of quality for all their interpretation needs."
F&S will introduce to its existing client base a new proprietary radiology workflow technology called AccuRad, Seidelmann said. This web-based workflow portal will permit clients to manage report delivery via automated fax, online access, or encrypted e-mail. AccuRad also offers real-time report status and enables referring physicians to view reports and images.
Future enhancements will include online order entry and referral volume analytics. F&S already provides its clients with support services such as credentialing, protocol training, professional billing, and marketing.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.